Exact Mass: 441.03241160000005

Exact Mass Matches: 441.03241160000005

Found 41 metabolites which its exact mass value is equals to given mass value 441.03241160000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Tizoxanide glucuronide

(2S,3S,4S,5R)-3,4,5-trihydroxy-6-[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenoxy]oxane-2-carboxylic acid

C16H15N3O10S (441.047813)


Tizoxanide glucuronide is a metabolite of nitazoxanide. Nitazoxanide, also known by the brand names Alinia and Annita (and by Daxon, Dexidex, Kidonax, Mitafar, Pacovanton, and Paramix in Mexico, by Nitax, Zox, Nitazox, Niazid and Toza in Bangladesh) is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent. Nitazoxanide is a light yellow crystalline powder. It is poorly soluble in ethanol and practically insoluble in water. (Wikipedia)

   

Glucomatronalin

3,4-dihydroxybenzyl glucosinolate

C14H19NO11S2 (441.0399504)


   
   

9-chloro-10b,11-dihydroxy-7,8-dimethoxy-2-methyl-3-methylene-11a-methylsulfanyl-2,3,6,10b,11,11a-hexahydro-5aH-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4-dione|Sporidesmin F

9-chloro-10b,11-dihydroxy-7,8-dimethoxy-2-methyl-3-methylene-11a-methylsulfanyl-2,3,6,10b,11,11a-hexahydro-5aH-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4-dione|Sporidesmin F

C18H20ClN3O6S (441.0761290000001)


   

Cys Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C13H23N5O6S3 (441.08104180000004)


   

Cys Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S3 (441.08104180000004)


   

Cys Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S3 (441.08104180000004)


   

Asn Cys Cys Cys

(2R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H23N5O6S3 (441.08104180000004)


   

3-Desethenyl-3-methyl Cefixime

3-Desethenyl-3-methyl Cefixime

C15H15N5O7S2 (441.041288)


   

sodium 3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonate

sodium 3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonate

C16H12N5NaO7S (441.0355122)


   

4-(3-(3-nitrophenylcarbamoyl) phenylsulfonamido) benzoic acid

4-(3-(3-nitrophenylcarbamoyl) phenylsulfonamido) benzoic acid

C20H15N3O7S (441.06306800000004)


   

[(η2-1,2-Ethynediyl)bis[trimethylsilane]](1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O′) copper

[(η2-1,2-Ethynediyl)bis[trimethylsilane]](1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O′) copper

C13H20CuF6O2Si2 (441.0201962)


   
   

ethyl 5-[4-[(4-bromo-5-methyl-1H-pyrrole-2-carbonyl)amino]piperidin-1-yl]-1,3,4-thiadiazole-2-carboxylate

ethyl 5-[4-[(4-bromo-5-methyl-1H-pyrrole-2-carbonyl)amino]piperidin-1-yl]-1,3,4-thiadiazole-2-carboxylate

C16H20BrN5O3S (441.0470150000001)


   
   

sodium p-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

sodium p-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

C16H12N5NaO7S (441.0355122)


   

Brimonidine tartrate

Brimonidine L-tartrate

C15H16BrN5O6 (441.0283896)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Brimonidine tartrate (UK 14304 tartrate) is a full α2-adrenergic receptor (α2-AR) agonist.

   

N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide

N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide

C18H11ClF3N3O3S (441.0161722)


   
   

N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide

N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide

C21H19N3O4S2 (441.08169340000006)


ML355 is a potent and selective inhibitor of 12-Lipoxygenase (12-LOX) with an IC50 of 0.34 μM, shows excellent selectivity over related lipoxygenases and cyclooxygenases, and possesses favorable ADME properties.

   
   

7-(4-Chlorophenyl)-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]-[1,2,4]triazolo[1,5-a]pyrimidine

7-(4-Chlorophenyl)-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]-[1,2,4]triazolo[1,5-a]pyrimidine

C17H8Cl2F3N5S (440.98295440000004)


   

3-[[[3-[(3-Nitrophenyl)sulfamoyl]phenyl]-oxomethyl]amino]benzoic acid

3-[[[3-[(3-Nitrophenyl)sulfamoyl]phenyl]-oxomethyl]amino]benzoic acid

C20H15N3O7S (441.06306800000004)


   

Phosphomethylphosphonic acid guanosyl ester

Phosphomethylphosphonic acid guanosyl ester

C11H17N5O10P2 (441.0450642)


   
   

GDP dianion

GDP dianion

C10H13N5O11P2-2 (441.00868080000004)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-[3-[(4-Azanyl-2-methoxy-pyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-5-yl]ethyl phosphono hydrogen phosphate

2-[3-[(4-Azanyl-2-methoxy-pyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-5-yl]ethyl phosphono hydrogen phosphate

C12H19N4O8P2S+ (441.0398814)


   

Methyl 2-[[8-(furan-2-yl)-4,4-dimethyl-5-oxa-11-thia-9,14,16-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-yl]sulfanyl]acetate

Methyl 2-[[8-(furan-2-yl)-4,4-dimethyl-5-oxa-11-thia-9,14,16-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),8,12(17),13,15-hexaen-13-yl]sulfanyl]acetate

C21H19N3O4S2 (441.08169340000006)


   

3-[5-[(Z)-(5-imino-7-oxo-3-phenyl-6-thiazolo[3,2-a]pyrimidinylidene)methyl]-2-furanyl]benzoic acid

3-[5-[(Z)-(5-imino-7-oxo-3-phenyl-6-thiazolo[3,2-a]pyrimidinylidene)methyl]-2-furanyl]benzoic acid

C24H15N3O4S (441.07832300000007)


   

3-[2-[(E)-2-cyano-2-(4-fluorophenyl)sulfonylethenyl]pyrrol-1-yl]sulfonylbenzonitrile

3-[2-[(E)-2-cyano-2-(4-fluorophenyl)sulfonylethenyl]pyrrol-1-yl]sulfonylbenzonitrile

C20H12FN3O4S2 (441.02532440000004)


   

ethyl 4-{5-[(E)-{2-[(5-bromopyridin-3-yl)carbonyl]hydrazinylidene}methyl]furan-2-yl}benzoate

ethyl 4-{5-[(E)-{2-[(5-bromopyridin-3-yl)carbonyl]hydrazinylidene}methyl]furan-2-yl}benzoate

C20H16BrN3O4 (441.03241160000005)


   
   

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxybutanedioic acid

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxybutanedioic acid

C15H16BrN5O6 (441.0283896)


   

5-(3-Bromophenyl)-1-(furan-2-ylmethyl)-4-(5-methylfuran-2-carbonyl)pyrrolidine-2,3-dione

5-(3-Bromophenyl)-1-(furan-2-ylmethyl)-4-(5-methylfuran-2-carbonyl)pyrrolidine-2,3-dione

C21H16BrNO5 (441.02117860000004)


   

XDP(3-)

XDP(3-)

C10H11N4O12P2 (440.98487259999996)


Trianion of xanthosine 5-diphosphate arising from deprotonation of all three OH groups of the diphosphate.

   

GDP(2-)

GDP(2-)

C10H13N5O11P2 (441.00868080000004)


An organophosphate oxoanion arising from deprotonation of two of the the three diphosphate OH groups of guanosine 5-diphosphate.